← Eichor
Study identifier: NCT05664737 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

Condition: Anemia  ·  Sponsor: Bristol-Myers Squibb

PhasePhase 2
Planned participants189
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of the study is to evaluate the efficacy and safety of luspatercept plus best supportive care (BSC) vs placebo plus BSC on anemia in adult participants with α-thalassemia hemoglobin H (HbH) disease and determine the safety and drug levels in adolescent participants.

This description comes directly from the study's public registry record.

Talk to the study team

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com  ·  855-907-3286  ·  Clinical.Trials@bms.com

First line of the email MUST contain NCT # and Site #.

Always discuss trial participation with your own doctor first.

Locations (36)

Local Institution - 0008Halifax, Nova Scotia, CanadaWithdrawn
Sun Yat-sen Memorial Hospital, Sun Yat-Sen UniversityGuangzhou, GD, ChinaRecruiting
Nanfang Hospital of Southern Medical UniversityGuangzhou, GD, ChinaRecruiting
The First People's Hospital of FoshanFoshan, Guangdong, ChinaRecruiting
Maoming People's HospitalMaoming Shi, Guangdong, ChinaRecruiting
Shenzhen Second People's HospitalShenzhen Shi, Guangdong, ChinaRecruiting
Liuzhou People's HospitalLiuzhou, Guangxi, ChinaRecruiting
People's Liberation Army The 923rd HospitalNanning, GX, ChinaRecruiting
Local Institution - 0011Haikou, Hainan, ChinaActive Not Recruiting
Local Institution - 0012Kunming, Yunnan, ChinaCompleted
Hainan General HospitalHaikou, ChinaRecruiting
The First Affiliated Hospital of Guangxi Medical UniversityNanning, ChinaRecruiting

+ 24 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05664737